Lombard Odier Asset Management (Switzerland)’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-645,086
Closed -$3.01M 365
2022
Q3
$3.01M Sell
645,086
-362,849
-36% -$2.29M 0.26% 92
2022
Q2
$5.97M Sell
1,007,935
-185,187
-16% -$2.06M 0.51% 48
2022
Q1
$23.1M Buy
1,193,122
+275,849
+30% +$6.33M 1.81% 19
2021
Q4
$30M Sell
917,273
-91,628
-9% -$3.69M 1.91% 11
2021
Q3
$41.4M Sell
1,008,901
-120,182
-11% -$4.36M 2.57% 1
2021
Q2
$40.7M Buy
1,129,083
+364,304
+48% +$13.4M 2.06% 1
2021
Q1
$29.8M Buy
+764,779
New +$34.4M 1.98% 6

Other funds holding GDRX

Lombard Odier Asset Management (Switzerland)'s GDRX Position: Q4 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 645,086 shares — an estimated $3.01M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in GDRX in Q1 2021 and held it in 7 quarters. The position peaked at $41.4M in Q3 2021. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 645,086 GoodRx Holdings shares in Q4 2022, an estimated $3.01M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in GoodRx Holdings in Q1 2021 and held it in 7 quarters.
  • Lombard Odier Asset Management (Switzerland)'s GoodRx Holdings position peaked at $41.4M in Q3 2021.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 14 Feb 2023.